DPA COVID-19 Policy Recommendations   [open pdf - 0B]

From the Document: "The Drug Policy Alliance (DPA) advances drug policies grounded in science, compassion, health, and human rights that are aimed at reducing harms of both drug prohibition and drug use. DPA is deeply concerned about our community members who are most vulnerable during the COVID-19 [coronavirus disease 2019] crisis, including people of color, people in jails, prisons, and immigrant detention centers, people otherwise entangled in the criminal legal system, people without housing, and people who use drugs, are accessing treatment, or are in recovery. These communities face unique challenges that put them at increased risk of various public health harms[.] [...] Racism, stigma, discrimination, and an inadequate social safety net, including barriers to healthcare, were impacting these communities long before COVID-19 but are amplified and compounded amid the current pandemic. People who use drugs will face even more challenges to accessing life-saving harm reduction services and medications for treatment than before. The racialized punishment of people who use drugs has not stopped, and additional policing, surveillance, and criminalization can be expected. People who are incarcerated and detained will remain stuck in crowded, unsanitary spaces. And people without housing will struggle to manage risks without adequate services, resources, or medical care. Immediate policy action is needed. DPA offers a place to start--a set of COVID-19 drug policy priorities to protect public health, individual rights, and the dignity and well-being of those in our communities who are most harmed by structural inequities."

Drug Policy Alliance
Retrieved From:
Drug Policy Alliance: https://drugpolicy.org/
Media Type:
Help with citations